Intrinsic Value of S&P & Nasdaq Contact Us

Stryker Corporation SYK NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
74/100
5/7 Pass
SharesGrow Intrinsic Value
$411.27
+18.9%
Analyst Price Target
$428.67
+23.9%

Stryker Corporation (SYK) — Analyst outlook / Analyst consensus target is. Based on 50 analyst ratings, the consensus is bullish — 1 Strong Buy, 35 Buy, 14 Hold.

The consensus price target is $428.67 (low: $390.00, high: $469.00), representing an upside of 23.9% from the current price $345.88.

Analysts estimate Earnings Per Share (EPS) of $12.05 and revenue of $22.52B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $7.86 vs est $12.05 (missed -34.8%). 2025: actual $8.49 vs est $13.56 (missed -37.4%). Analyst accuracy: 43%.

SYK Stock — 12-Month Price Forecast

$428.67
▲ +23.94% Upside
Average Price Target
Based on 50 Wall Street analysts offering 12-month price targets for Stryker Corporation, the average price target is $428.67, with a high forecast of $469.00, and a low forecast of $390.00.
The average price target represents a +23.94% change from the last price of $345.88.
Highest Price Target
$469.00
Average Price Target
$428.67
Lowest Price Target
$390.00

SYK Analyst Ratings

Buy
50
Ratings
36 Buy
14 Hold
Based on 50 analysts giving stock ratings to Stryker Corporation in the past 3 months
Rating breakdown
Strong Buy
1 2%
Buy
35 70%
Hold
14 28%
72%
Buy
36 analysts
28%
Hold
14 analysts
0%
Sell
0 analysts

EPS Estimates — SYK

43%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024 Actual $7.86 vs Est $12.05 ▼ 53.4% off
2025 Actual $8.49 vs Est $13.56 ▼ 59.8% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is improving. Analysts forecast meaningful EPS growth ahead.

Revenue Estimates — SYK

100%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024 Actual $22.595B vs Est $22.523B ▲ 0.3% off
2025 Actual $25.116B vs Est $25.066B ▲ 0.2% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message